布瓦西坦
Catalog No: 16122906
CAS Number: 357336-20-0
Purity: 98%
Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties approved for the treatment of epilepsy. Brivaracetam is believed to act by binding to the ubiquitous synaptic vesicle glycoprotein 2A (SV2A), like levetiracetam. SV2A plays a role in exocytosis of various neurotransmitters. Brivaracetam was approved to treat partial-onset seizures with or without secondary generalisation, in combination with other antiepileptic drugs.
仅供研究使用。 我们不向患者出售。
Chemical Information
| Name | 布瓦西坦 |
|---|---|
| Iupac Chemical Name | (S)-2-((R)-2-oxo-4-propylpyrrolidin-1-yl)butanamide |
| Synonyms | UCB 34714 ; UCB-34714 ; UCB34714 ; Briviact ; Brivaracetam |
| 英文同义词 | UCB 34714 ; UCB-34714 ; UCB34714 ; Briviact ; Brivaracetam |
| Molecular Formula | C11H20N2O2 |
| Molecular Weight | 212.293 |
| Smile | CC[C@H](N1C(C[C@@H](CCC)C1)=O)C(N)=O |
| InChiKey | MSYKRHVOOPPJKU-BDAKNGLRSA-N |
| InChi | InChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1 |
| CAS Number | 357336-20-0 |
| MDL | MFCD13152385 |
| 相关CAS号 | 357336-20-0 |
Ordering Information
| 包装 | Price | 库存 | Purity | 备货期 |
|---|---|---|---|---|
| 大货 | Enquiry | Enquiry | Enquiry |
| 外观性状 | crystalline solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | Soluble in DMSO |
| 处理方式 | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| 海关编码 |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
